Catherine Cassiman

Universitaire Ziekenhuizen KU Leuven

QC-verified· April 2026 PI on 1 trial

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Neurofibromatosis type 1

Clinical trials (1)

NCT02078401

Verify independently

ClinicalTrials.gov PI search for Catherine Cassiman

Other specialists for Neurofibromatosis type 1

Peers ranked by clinical-trial PI role, publications, and verification quality.

Carlos G Romo, MD
Johns Hopkins University
Maryland
Miriam Bornhorst, MD
Children's National Health System
District of Columbia
Pamela L Wolters, Ph.D.
National Cancer Institute (NCI)
District of Columbia
Wenbin Li, MD
Cancer Hospital Chinese Academy of Medical Sciences
Beijing Municipality
Shivani Ahlawat, PhD
Johns Hopkins University
Maryland
Mary Kay Koenig, MD
The University of Texas Medical School at Houston
Texas
Brigitte C. Widemann, MD, M.D
National Cancer Institute (NCI)
MD
Brigitte C Widemann, M.D.
National Cancer Institute (NCI)
Maryland

See all specialists for Neurofibromatosis type 1 →

← Back to specialists directory